Key metrics and charts across all fundamental categories.
Stock price and market valuation
CVX trades at $171.845, a 2.7% increase year-over-year. Market capitalization stands at $340.28B, up 16.6% from the prior year. Track CVX price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$190.03B in TTM revenue declined 5.8% YoY, reaching $48.61B last quarter. TTM EBITDA of $38.71B on operating income of $3.64B shows growth is flowing through. Net income of $11.01B TTM confirms the company is converting revenue into profit. Revenue is contracting — assess whether this is cyclical or structural.
Assets, cash, debt, and leverage
With $329.55B in assets and $39.60B in long-term debt, the D/E of 0.2 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 30.9x P/E, the stock trades at a premium — the market expects above-average growth. P/S of 1.8x and P/B of 1.9x provide additional context. The premium P/E is not backed by strong revenue growth — the stock may be overvalued.
Operating efficiency and return metrics
Op. margin of 7.5% is down 2.8% YoY — costs are rising relative to revenue. Net margin at 4.5% and gross margin of 41.8%. ROE of 6.0% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $-1.55B on $2.51B in operating cash flow. The FCF / Net Income ratio of -0.1x shows cash consumption — the business is not yet self-funding. Cash reserves of $5.32B provide financial flexibility. Shares outstanding rose 13.5% YoY — shareholder dilution is eroding per-share value.
